Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

CD141⁺ myeloid dendritic cells are enriched in healthy human liver.

Kelly A, Fahey R, Fletcher JM, Keogh C, Carroll AG, Siddachari R, Geoghegan J, Hegarty JE, Ryan EJ, O'Farrelly C.

J Hepatol. 2014 Jan;60(1):135-42. doi: 10.1016/j.jhep.2013.08.007. Epub 2013 Aug 19.

PMID:
23968887
2.

Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.

Kassianos AJ, Wang X, Sampangi S, Muczynski K, Healy H, Wilkinson R.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1391-401. doi: 10.1152/ajprenal.00318.2013. Epub 2013 Sep 18.

3.

Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.

Yu H, Zhang P, Yin X, Yin Z, Shi Q, Cui Y, Liu G, Wang S, Piccaluga PP, Jiang T, Zhang L.

Protein Cell. 2015 Apr;6(4):297-306. doi: 10.1007/s13238-015-0140-x. Epub 2015 Mar 18.

4.

Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.

Yoshio S, Kanto T, Kuroda S, Matsubara T, Higashitani K, Kakita N, Ishida H, Hiramatsu N, Nagano H, Sugiyama M, Murata K, Fukuhara T, Matsuura Y, Hayashi N, Mizokami M, Takehara T.

Hepatology. 2013 May;57(5):1705-15. doi: 10.1002/hep.26182. Epub 2013 Mar 14.

PMID:
23213063
5.

Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis.

Hayashi Y, Ishii Y, Hata-Suzuki M, Arai R, Chibana K, Takemasa A, Fukuda T.

Respir Res. 2013 Mar 4;14:29. doi: 10.1186/1465-9921-14-29.

6.

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJ, Hart DN, Radford KJ.

J Exp Med. 2010 Jun 7;207(6):1247-60. doi: 10.1084/jem.20092140. Epub 2010 May 17.

7.

Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Zhang S, Kodys K, Li K, Szabo G.

Gastroenterology. 2013 Feb;144(2):414-425.e7. doi: 10.1053/j.gastro.2012.10.034. Epub 2012 Oct 23.

8.
9.

Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function.

Lai WK, Curbishley SM, Goddard S, Alabraba E, Shaw J, Youster J, McKeating J, Adams DH.

J Hepatol. 2007 Sep;47(3):338-47. Epub 2007 Apr 12.

PMID:
17467113
10.

Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure.

Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu YJ, Wang FS.

J Hepatol. 2008 Sep;49(3):396-406. doi: 10.1016/j.jhep.2008.05.017. Epub 2008 Jun 12.

PMID:
18644645
11.

Characterization of myeloid and plasmacytoid dendritic cells in human lung.

Masten BJ, Olson GK, Tarleton CA, Rund C, Schuyler M, Mehran R, Archibeque T, Lipscomb MF.

J Immunol. 2006 Dec 1;177(11):7784-93.

12.

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.

J Immunol. 2003 Oct 15;171(8):4320-8.

13.

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

Sittig SP, Bakdash G, Weiden J, Sköld AE, Tel J, Figdor CG, de Vries IJ, Schreibelt G.

Mediators Inflamm. 2016;2016:3605643. doi: 10.1155/2016/3605643. Epub 2016 Feb 7.

14.

Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.

Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, Szabo G.

PLoS One. 2012;7(10):e44915. doi: 10.1371/journal.pone.0044915. Epub 2012 Oct 10.

15.

Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness.

Hémont C, Neel A, Heslan M, Braudeau C, Josien R.

J Leukoc Biol. 2013 Apr;93(4):599-609. doi: 10.1189/jlb.0912452. Epub 2013 Jan 22.

PMID:
23341538
16.

Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients.

Lebre MC, van Capel TM, Bos JD, Knol EF, Kapsenberg ML, de Jong EC.

J Allergy Clin Immunol. 2008 Nov;122(5):969-976.e5. doi: 10.1016/j.jaci.2008.08.028. Epub 2008 Oct 9.

PMID:
18845325
17.

NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.

Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, Fischer JA, Weiss S, Kalinke U, Kunz S, Bogdan C.

J Exp Med. 2007 Apr 16;204(4):893-906. Epub 2007 Mar 26.

18.

Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.

Velazquez VM, Hon H, Ibegbu C, Knechtle SJ, Kirk AD, Grakoui A.

Hepatology. 2012 Dec;56(6):2071-81. doi: 10.1002/hep.25904.

19.

FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.

Ding Y, Wilkinson A, Idris A, Fancke B, O'Keeffe M, Khalil D, Ju X, Lahoud MH, Caminschi I, Shortman K, Rodwell R, Vuckovic S, Radford KJ.

J Immunol. 2014 Feb 15;192(4):1982-9. doi: 10.4049/jimmunol.1302391. Epub 2014 Jan 22.

20.

Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli.

Kassianos AJ, Hardy MY, Ju X, Vijayan D, Ding Y, Vulink AJ, McDonald KJ, Jongbloed SL, Wadley RB, Wells C, Hart DN, Radford KJ.

Eur J Immunol. 2012 Jun;42(6):1512-22. doi: 10.1002/eji.201142098.

Supplemental Content

Support Center